Nguyen Tung, Shively John E
From the Department of Immunology, Beckman Research Institute of City of Hope, Duarte, California 91010.
From the Department of Immunology, Beckman Research Institute of City of Hope, Duarte, California 91010
J Biol Chem. 2016 Aug 5;291(32):16766-76. doi: 10.1074/jbc.M115.710160. Epub 2016 Jun 14.
Concomitant loss of lumen formation and cell adhesion protein CEACAM1 is a hallmark feature of breast cancer. In a three-dimensional culture model, transfection of CEACAM1 into MCF7 breast cells can restore lumen formation by an unknown mechanism. ID4, a transcriptional regulator lacking a DNA binding domain, is highly up-regulated in CEACAM1-transfected MCF7 cells, and when down-regulated with RNAi, abrogates lumen formation. Conversely, when MCF7 cells, which fail to form lumena in a three-dimensional culture, are transfected with ID4, lumen formation is restored, demonstrating that ID4 may substitute for CEACAM1. After showing the ID4 promoter is hypermethylated in MCF7 cells but hypomethylated in MCF/CEACAM1 cells, ID4 expression was induced in MCF7 cells by agents affecting chromatin remodeling and methylation. Mechanistically, CaMK2D was up-regulated in CEACAM1-transfected cells, effecting phosphorylation of HDAC4 and its sequestration in the cytoplasm by the adaptor protein 14-3-3. CaMK2D also phosphorylates CEACAM1 on its cytoplasmic domain and mutation of these phosphorylation sites abrogates lumen formation. Thus, CEACAM1 is able to maintain the active transcription of ID4 by an epigenetic mechanism involving HDAC4 and CaMK2D, and the same kinase enables lumen formation by CEACAM1. Because ID4 can replace CEACAM1 in parental MCF7 cells, it must act downstream from CEACAM1 by inhibiting the activity of other transcription factors that would otherwise prevent lumen formation. This overall mechanism may be operative in other cancers, such as colon and prostate, where the down-regulation of CEACAM1 is observed.
管腔形成和细胞粘附蛋白癌胚抗原相关细胞粘附分子1(CEACAM1)的同时缺失是乳腺癌的一个标志性特征。在三维培养模型中,将CEACAM1转染到MCF7乳腺癌细胞中可通过未知机制恢复管腔形成。ID4是一种缺乏DNA结合结构域的转录调节因子,在CEACAM1转染的MCF7细胞中高度上调,当用RNA干扰下调时,可消除管腔形成。相反,当在三维培养中不能形成管腔的MCF7细胞转染ID4时,管腔形成得以恢复,表明ID4可能替代CEACAM1。在显示ID4启动子在MCF7细胞中高度甲基化但在MCF/CEACAM1细胞中低甲基化后,通过影响染色质重塑和甲基化的试剂在MCF7细胞中诱导了ID4表达。从机制上讲,钙/钙调蛋白依赖性蛋白激酶2D(CaMK2D)在CEACAM1转染的细胞中上调,导致组蛋白去乙酰化酶4(HDAC4)磷酸化并通过衔接蛋白14-3-3将其隔离在细胞质中。CaMK2D还使其细胞质结构域上的CEACAM1磷酸化,这些磷酸化位点的突变可消除管腔形成。因此,CEACAM1能够通过涉及HDAC4和CaMK2D的表观遗传机制维持ID4的活性转录,并且相同的激酶可使CEACAM1形成管腔。因为ID4可以在亲本MCF7细胞中替代CEACAM1,它必须通过抑制其他否则会阻止管腔形成的转录因子的活性在CEACAM1下游起作用。这种整体机制可能在其他癌症中起作用,例如在观察到CEACAM1下调的结肠癌和前列腺癌中。